Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Regenxbio: Q4 Earnings Insights

Regenxbio (NASDAQ:RGNX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Regenxbio beat estimated earnings by 41.61%, reporting an EPS of $6.67 versus an estimate of $4.71.

Revenue was up $377.21 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.29 which was followed by a 3.14% increase in the share price the next day.

Here's a look at Regenxbio's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -1.08 -1.12 -1.28 -0.43
EPS Actual -1.37 -1.36 -1.20 -1.24
Revenue Estimate 41.46M 29.02M 23.23M 61.50M
Revenue Actual 30.77M 22.04M 18.88M 21.45M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.